David Carley,Kenton Fedde,John KOLENG,Peter LETENDRE
申请号：
US13474666
公开号：
US20120231083A1
申请日:
2012.05.17
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides a medicament which results in delivery of a therapeutic level of one or more cannabinoids during a clinically relevant therapeutic window. The therapeutic window is a longer window than provided by an immediate release medicament such as Marinol containing an equivalent amount of the cannabinoid. Oral administration of the present compositions provides therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of treating cannabinoid-sensitive disorders.
